-->

Tag: Early-stage lung cancer drugs

Home / Early-stage lung cancer drugs

Categories

Neoadjuvant/adjuvant durvalumab is approved by the USFDA for resectable non-small cell lung cancer

August 2024: The Food and Drug Administration has granted approval for the use of durvalumab (Imfinzi, AstraZeneca) in combination with platinum-containing chemotherapy as a neoadjuvant treatment, fol...
early-stage-lung-cancer-drugs

Alectinib has been approved by the USFDA as adjuvant treatment for ALK-positive non-small cell lung cancer

Alectinib approved in the treatment of non-small cell lung cancer The Food and Drug Administration (FDA) has approved the drug Alecensa, made by Genentech, Inc. It can be used as an extra treatment f...
early-stage-lung-cancer-drugs

Scan the code